---

• n  a monoamine neurotransmitter found in the brain and essential for the normal functioning of the central nervous system; as a drug (trade names Dopastat and Intropin) it is used to treat shock and hypotension

• If risk-taking behavior looks like addiction, there may be a biological reason for that: both behaviors involve the brain's feel-good chemical, dopamine.
• The neurotransmitter dopamine ranks among the most powerful of the brain's master molecules.
• The enzyme breaks down dopamine, a chemical messenger in the brain associated with feelings of pleasure.

• Dopastat
• Intropin

News & Articles

---

• High sugar intake linked to low dopamine release in insulin resistant patients
  ( Society of Nuclear Medicine ) Researchers have identified a sweet spot that operates in a disorderly way when simple sugars are introduced to people with insulin resistance, a precursor to type 2 diabetes. For those who have the metabolic syndrome, a sugar drink resulted in a lower-than-normal release of the chemical dopamine in a major pleasure center of the brain. This chemical response may ...
  June 11, 2013 - EurekAlert!
• Playing With Dogs May Help Teens Treated for Substance Abuse
  New research suggests playing with dogs can improve the mood of teens being treated for drug or alcohol abuse in a residential treatment center. Dog therapy may help stimulate the release of the feel-good chemical dopamine in the brain, the researchers say.
  June 7, 2013 - Join Together Online
• How to use gamification to engage employees
  Gamification is the process of using game thinking and game mechanics to solve problems and engage users, according to Gabe Zichermann, author of the upcoming book "The Gamification Revolution" and founder of Dopamine, a consulting agency focused on gamified campaigns for employees and consumers. read more
  June 6, 2013 - IT World

Quotes

---

• Helen Fisher in FOXNews
  These are cells that make dopamine and send it to different brain regions,said Helen Fisher, a researcher and professor at Rutgers University. "This part of the system becomes activated because you're trying to win life's greatest prize _...
• Paul Greengard in News-Medical.net
  Blocking the dopamine D1 receptor is not a treatment option for L-DOPA-induced side effects, since it would diminish the therapeutic efficiency of L-DOPA,says Greengard, who is Vincent Astor Professor and head of the Laboratory of Molecular...